Acorda Therapeutics (ACOR) Tops Q1 EPS by 18c
Get Alerts ACOR Hot Sheet
Price: $13.50 +8.87%
EPS Growth %: -139.7%
Financial Fact:
Total operating expenses: 141.09M
Today's EPS Names:
BFRI, HCTI, IMPM, More
EPS Growth %: -139.7%
Financial Fact:
Total operating expenses: 141.09M
Today's EPS Names:
BFRI, HCTI, IMPM, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q1 EPS of $0.36, $0.18 better than the analyst estimate of $0.18. Revenue for the quarter came in at $71.25 million versus the consensus estimate of $70.95 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FreightCar America (RAIL) Misses Q4 EPS by 6c, provides guidance
- Tenaya Therapeutics, Inc. (TNYA) Tops Q4 EPS by 3c
- Red Cat Holdings Inc. (RCAT) Misses Q3 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!